Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma
Health Briefs
Related Stories
Health Briefs
Oct 07, 2025
FDA grants Breakthrough Therapy Designation to Angelman Syndrome treatment
Health Briefs
Oct 01, 2025
Dr. Mustafa Sahin gives Cain Labs' Inaugural John Swann Lecture in Epilepsy Series September 29, ...
73566
Health Briefs
Article